Last updated: 11/04/2018 11:58:10

Study In Asthma Control

GSK study ID
SFA103081
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Other
Other
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: An open-label, multi-centre, randomized, parallel group clinical effectiveness study to determine the level of asthma control in adolescent and adult patients with ADVAIR versus usual care for 24 weeks.
Trial description: This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
None (Open Label)
Allocation:
Randomized
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
  • Drug: salmeterol xinafoate/fluticasone propionate
  • Enrollment:
    680
    Primary completion date:
    Not applicable
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Not applicable
    Medical condition
    Asthma
    Product
    fluticasone propionate, salmeterol
    Collaborators
    Not applicable
    Study date(s)
    November 2004 to March 2006
    Type
    Interventional
    Phase
    4

    Participation criteria

    Sex
    Female & Male
    Age
    12+ years
    Accepts healthy volunteers
    No
    • documented clinical history of asthma and receiving regular maintenance therapy.
    • Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1.
    • History of heavy smoking or substance abuse.

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Chicoutimi, Québec, Canada, G7H 2W3
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Regina, Saskatchewan, Canada, S4S 0A2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brampton, Ontario, Canada, L6T 3T1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M9N 1X7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Courcelette, Québec, Canada, G0A 1R1
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6B 2E8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M4M 1J5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Renfrew, Ontario, Canada, K7V 1P6
    Status
    Study Complete
    Location
    GSK Investigational Site
    North York, Ontario, Canada, M2J 1V1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5A 4L8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Niagara Falls, Ontario, Canada, L2E 6A6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M5G 1E2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamilton, Ontario, Canada, L8L 5G8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charlesbourg, Québec, Canada, G1G 4A2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, British Columbia, Canada, V7C 5L9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Calgary, Alberta, Canada, T3E 7C4
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H2L 2W5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sainte-Foy, Québec, Canada, G1V 4P9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Abbotsford, British Columbia, Canada, V2S 6R6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kelowna, British Columbia, Canada, V1Y 9L8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M2K 2W2
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Newmarket, Ontario, Canada, L3Y 5G8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5B 3A8
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Oshawa, Ontario, Canada, L1J 2K9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burlington, Ontario, Canada, L7M 4Y1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L4Z 3J1
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Salle, Québec, Canada, H2N 1T9
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Holyrood, Newfoundland and Labrador, Canada, A0A 2R0
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moncton, New Brunswick, Canada, E1G 1A7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Halifax, Nova Scotia, Canada, B3H 1Y6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Scarborough, Ontario, Canada, M1B 4Z8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Erie, Ontario, Canada, L2A 1Z3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ville Lasalle, Québec, Canada, H8N 1X9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Coquitlam, British Columbia, Canada, V3K 3P4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamilton, Ontario, Canada, L8P 3A9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thornhill, Ontario, Canada, L3T 4X1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R3C 0N2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oshawa, Ontario, Canada, L1G 7W4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8X 5A6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6A 4G5
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Trois Rivières, Québec, Canada, G8T 7A1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Regina, Saskatchewan, Canada, S4V 3A6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Penticton, British Columbia, Canada, V2A 5C8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kingston, Ontario, Canada, K7M 1W9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brandon, Manitoba, Canada, R7A 5E7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brampton, Ontario, Canada, L6T 4S5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Surrey, British Columbia, Canada, V4H 2H9
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6C 4Y7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M5B 1W8
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6P 1A9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H4N 2W2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamilton, Ontario, Canada, L8M 1K7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sudbury, Ontario, Canada, P3E 4M8
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Steinbach, Manitoba, Canada, R5G 1T7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chilliwack, British Columbia, Canada, V2P 4M9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M8V 3X8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond Hill, Ontario, Canada, L4C 2N9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barrie, Ontario, Canada, L4M 5G1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mount Pearl, Newfoundland and Labrador, Canada, A1N 5B6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M4X 1W4
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mount Pearl, Newfoundland and Labrador, Canada, A1N 2C1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8W 5L7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Halifax, Nova Scotia, Canada, B3H 4M2
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hamilton, Ontario, Canada, L8L 2Z5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Québec, Québec, Canada, G1V 4M6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oshawa, Ontario, Canada, L1H 1B9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bridgewater, Nova Scotia, Canada, B4V 3N2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kitchener, Ontario, Canada, N2C 2N9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Romuald, Québec, Canada, G6W 3M6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5C OA3
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Niagara Falls, Ontario, Canada, L2G 1J4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Upper Tantallon, Nova Scotia, Canada, B3Z 1E3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sainte Jerome, Québec, Canada, J7Z 5T3
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    London, Ontario, Canada, N5Y 5K7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saine-Eustache, Québec, Canada, J7P 2V1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond Hill, Ontario, Canada, L4C 3Y1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint John's, Newfoundland and Labrador, Canada, A1A 2H1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H3S 2W1
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Catherines, Ontario, Canada, L2T 3Y4
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kanata, Ontario, Canada, K2L 3C8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Abbotsford, British Columbia, Canada, V2S 3N8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cowansville, Québec, Canada, J2K 2X9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5G 3G6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    North York, Ontario, Canada, M3M 3E5
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6K 4L2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Princeville, Québec, Canada, G6L 5A3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M3J 1N2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Contrecoeur, Québec, Canada, J0L 1C0
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Saskatoon, Saskatchewan, Canada, S7K 3H3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bay Roberts, Newfoundland and Labrador, Canada, A0G 1G0
    Status
    Study Complete
    Location
    GSK Investigational Site
    North York, Ontario, Canada, M2M 4J5
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5B 4A9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M4V 1R2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M5T 3A9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint John's, Newfoundland and Labrador, Canada, A1A 3R5
    Status
    Study Complete
    Location
    GSK Investigational Site
    St-Bruno, Québec, Canada, G0W 2L0
    Status
    Study Complete
    Location
    GSK Investigational Site
    North Bay, Ontario, Canada, P1B 2H3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Delta, British Columbia, Canada, V4K 2K5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Peterborough, Ontario, Canada, K9H 1T6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H3T 1Y6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Calgary, Alberta, Canada, T3C 3P1
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Longueuil, Québec, Canada, J4J 2H3
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    LeGardeur, Québec, Canada, J5Z 3C4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8W 1E6
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6H 4P2
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Brossard, Québec, Canada, J4Z 2K9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5N 2N8
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Lasalle, Québec, Canada, H8N 1T9
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5M 2V8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brantford, Ontario, Canada, N3R 4N3
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R3G 0W4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H4W 1S7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Prescott, Ontario, Canada, K0E 1T0
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R2M 5L9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bolton, Ontario, Canada, L7E 1E8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rothesay, New Brunswick, Canada, E2E 2R1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ajax, Ontario, Canada, L1S 2J5
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M4T 1K2
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Maple Ridge, British Columbia, Canada, V2X 2L5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chateauguay, Québec, Canada, J6K 3A9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burnaby, British Columbia, Canada, V5G 1T4
    Status
    Study Complete
    Location
    GSK Investigational Site
    North York, Ontario, Canada, M2J 1W8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kamloops, British Columbia, Canada, V2C 5R9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H1K 1N4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sudbury, Ontario, Canada, P3E 3C6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5A 1N1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saskatoon, Saskatchewan, Canada, S7K 7H9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sainte Catherine, Québec, Canada, J0L 1E0
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trois Rivieres, Québec, Canada, G9A 4K7
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Trenton, Ontario, Canada, K8V 1M2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8X 3V6
    Status
    Study Complete

    Study documents

    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Other
    Actual primary completion date
    Not applicable
    Actual study completion date
    2006-28-03

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Additional information
    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website